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As most studies overestimate the cumulative pregnancy 
rate, a method is proposed to estimate a more realistic 
cumulative pregnancy rate by taking into account the 
reasons for an early cessation of treatment with in-vitro 
fertilization (IVF), Three methods for calculating cumu­
lative pregnancy rates were compared. The first method 
assumed that those who stopped treatment had no chance 
at all of pregnancy. The second method, the one used most 
often, assumed the same probability of pregnancy for those 
who stopped as for those who continued. The third method 
assumed that only those who stopped treatment, because 
of a medical indication, had no chance at all of pregnancy 
and that the others who stopped had the same probability 
of pregnancy as those who continued treatment. Data were 
used from 616 women treated at the University Hospital 
Nijmegen, Nijmegen, The Netherlands. The cumulative 
pregnancy rates after five initiated IVF cycles for the three 
calculation methods were in the ranges 37-51% for the 
positive pregnancy test result, 33-55 % for a clinical preg­
nancy and 30-56% for an ongoing pregnancy. As expected, 
the first method underestimated the cumulative pregnancy 
rate and the second overestimated it. The third method 
produced the most realistic cumulative pregnancy rates. 
Key words: epidemiology/in-vitro fertilization/pregnancy rate/ 
statistics
Introduction
Information about the probability of pregnancy after successive 
treatments with in-vitro fertilization (IVF) is important for 
candidate patients and for the physicians who are counselling 
them. Several authors have reported cumulative pregnancy 
rates and recognized the importance of the variation in 
patient populations and treatment, including age, type of 
infertility and ovulation stimulation regimen, on the cumu­
lative pregnancy rates (Guzick et a l , 1986; Tan et a l,  1992, 
1994a,b; Simon et a l , 1993; Check et a l 5 1994). Far less 
attention has been paid to the impact on cumulative pregnancy
rates of the reason for the early cessation of IVF treatment 
(Page, 1989; Te Velde et a l,  1992; De Mouzon et a l , 1993).
As it is neither ethical nor practical to force patients to 
continue IVF treatments until pregnancy or for a fixed number 
of treatments (e.g, at least five), the real cumulative pregnancy 
rate after five IVF cycles for a specific population cannot be 
calculated. Therefore, to estimate the cumulative pregnancy 
rate, assumptions are necessary about the probability of the 
occurrence of pregnancy for those who discontinue treatment 
without achieving pregnancy. Most studies assume implicitly 
that all the patients who stop treatment early have the same 
probability of pregnancy as those who continue (Guzick et a l , 
1986; Hull et a l , 1992; Tan et a l , 1992, 1994a,b; Simon 
et a l , 1993; Check et a l , 1994). Haan et al  (1991) noted 
the importance of selective early cessation but compared the 
cumulative rate based on the assumption that the pregnancy 
rate of the first IVF treatment held good for the following IVF 
treatments with the cumulative rate based on the assumption 
that the same chance of pregnancy could be applied to 
women who stopped treatment early compared with those who 
continued treatment. Both of these methods will overestimate 
the real probability of pregnancy after successive IVF treat­
ments. The other extreme, i.e. assuming that the women who 
stop IVF treatment early will never become pregnant, will 
obviously underestimate the cumulative pregnancy rate. The 
examples below show how large the bias can be.
Recently Tan et al  (1994a) presented a cumulative live 
birth rate of 68.6% after five IVF treatments in women who 
had previously achieved an IVF live birth. A life-table analysis 
was used because it takes into account the experience of the 
entire cohort by using all the treatment cycles. However, this 
method implicitly assumes that the women who stopped IVF 
treatment early (in this case before the fifth treatment) had the 
same probability of having a live birth as those who continued 
treatment. Using the number of women per IVF treatment and 
the cumulative live birth rates, the calculated numbers of live 
births following each of the five IVF treatments were 21 in 
105 women after the first treatment, six in 48 after the second, 
one in 30 after the third, one in 14 after the fourth and four 
in eight after the fifth. If we assume that none of the women 
who stop treatment early will ever achieve a live birth, the 
cumulative live birth rate would be 31%. The actual rate would 
be higher of course, but certainly not as high as the 68.6% 
presented by Tan et al (1994a).
In the same manner, Guzick et a l  (1986) calculated the 
cumulative rates for clinical pregnancy in treatments where 
oocyte retrieval was performed, excluding couples in whom 
the male partner had poor semen characteristics. They 
reported a cumulative pregnancy rate after six cycles of
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Table I. Cumulative pregnancy rates for successive in-vitro fertilization (IVF) treatments calculated on the basis of three assumptions
IVF treatment No. of women who
became pregnant
No. of women who 
stopped treatment1
No. of women at riskb Cumulative pregnancy rate (%)
AIc’f AIId'S AIIIe*h AI All AIII
Positive pregnancy test result
I 131 120 616 616 616 21.3 21.3 21.3
2 56 102 485 365 407 30.4 33.3 32.1
3 34 133 429 207 307 35.9 44.3 39.6
4 5 31 395 40 179 36.7 51.3 41.3
5 0 — 390 4 158 36.7 51.3 41.3
Clinical pregnancy
1 112 123 616 616 616 18.2 18.2 18.2
2 56 105 504 381 423 27.3 30.2 29.0
3 33 140 448 220 320 32.6 40.7 36.3
4 4 37 415 47 186 33.3 45.7 37.7
5 1 — 411 6 160 33.4 54.8 38.1
Ongoing pregnancy
1 94 127 616 616 616 15.3 15.3 15.3
2 49 109 522 395 437 23.2 25.8 24.8
3 33 148 473 237 337 28.6 36.1 32.1
4 3 42 440 56 195 29.1 39.5 33.2
5 3 437 11 165 29.5 56.0 34.4
aWomen who stopped after this treatment without becoming pregnant. 
bNumber of women who did not become pregnant in the previous IVF treatment(s).
0Assumption I (Al): women who stopped treatment had no chance of becoming pregnant,
dAssumption II (Ail): women who stopped treatment had the same probability of pregnancy as those who continued.
Assumption III (AIII): women who stopped treatment because of a medical indication had no chance of becoming pregnant, while those who stopped 
treatment for other reasons had the same probability of pregnancy as those who continued.
*Women included who stopped treatment after the foregoing IVF treatment(s) without becoming pregnant, 
gWomen excluded who stopped treatment after the foregoing IVF treat ment(s) without becoming pregnant.
hWomen who stopped treatment because of a medical indication included; women who stopped treatment for other reasons excluded (in comparison with 
those at risk in the case of assumption II, for IVF treatment 2, +42; for treatment 3, +100; for treatment 4, +139; and for treatment 5, +154),
59.6%. Furthermore, they predicted the cumulative pregnancy 
rates after nine and 12 cycles to be 75 and 84% respectively. 
As all these calculations implicitly assumed the probability of 
pregnancy for those who stopped treatment early to be the 
same as for those who continued treatment, these rates are 
overestimated. Here, the assumption that those who stopped 
treatment early would not become pregnant leads to a cumu­
lative pregnancy rate of 27% after six cycles. The actual rate 
would be between 27 and 59.6%, analogous to the first 
example.
More precise estimates of the cumulative pregnancy rates 
can be made if the reason for the early cessation of treatment 
is known. If, for instance, women stop treatment for financial 
or emotional reasons, they can be expected to have a higher 
probability of achieving a pregnancy than those who stop 
treatment because of poor IVF results such as low fertilization 
rates and poor embryo quality. To illustrate the importance of 
the assumption underlying the estimation of the cumulative 
pregnancy rates, here cumulative pregnancy rates have been 
calculated for patients of the University Hospital Nijmegen, The 
Netherlands during 1988-1993. Estimations of the cumulative 
pregnancy rates, assuming a difference in the probability of 
pregnancy for specific reasons for the discontinuation of 
treatment, were compared with those based on more extreme 
assumptions.
Materials and methods
At the University Hospital Nijmegen, The Netherlands, 872 women 
were treated for the first time with IVF between August 1, 1988 and
January 1, 1993, In this study only women were included who were 
treated with human menopausal gonadotrophin in combination with 
a long protocol of gonadotrophin-releasing hormone agonist, with or 
without oral contraceptives during the preceding menstrual cycle, and 
who did not use donor spermatozoa (n = 616). Only the results of 
the first five initiated IVF treatments were analysed (whether or 
not oocyte aspiration and embryo transfer were performed). Three 
definitions of pregnancy were used: (i) positive pregnancy test result, 
measured 16 days after embryo transfer; (ii) clinical pregnancy — a 
positive pregnancy test result and ultrasonographic evidence of at 
least one gestational sac 4 weeks after embryo transfer; and (iii) 
ongoing pregnancy — a pregnancy continuing for >12 weeks after 
embryo transfer. To calculate the cumulative rates for each of these 
types of pregnancy, only the data up to the first pregnancy in question 
were included in the analysis. To be clear, data were also included if 
women did not achieve pregnancy during the first five treatments.
Three assumptions were used to deal with the effect of the early 
cessation of IVF treatment (i.e. before a woman became pregnant): 
assumption I, women who stopped treatment had no chance of 
becoming pregnant; assumption II, women who stopped treatment 
had the same probability of becoming pregnant as those who 
continued; and assumption III, only the women who stopped treatment 
because of a medical indication had no chance of becoming pregnant, 
while the women who stopped treatment for other reasons had the 
same probability of pregnancy as those who continued treatment. A 
medical indication for stopping further IVF treatment was assumed 
to include: (i) a previous treatment with a fertilization rate of <10%, 
despite the presence of more than three large follicles (^15 mm) on 
the day of human chorionic gonadotrophin (HCG) administration and 
the performance of oocyte aspiration, or (it) three or less large 
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Figure 1. Cumulative rates for a positive pregnancy test result (A), 
clinical pregnancy (B) and ongoing pregnancy (C) for successive 
in-vitro fertilization (IVF) treatments calculated on the basis of
three assumptions; (-----) assumption I, women who stopped
treatment had no chance of becoming pregnant; (.... ) assumption II,
women who stopped treatment had the same probability of 
pregnancy as those who continued; and (—) assumption III, women 
who stopped treatment because of a medical indication had no 
chance of becoming pregnant, while those who stopped for other 
reasons had the same probability of pregnancy as those who 
continued treatment.
The cumulative pregnancy rate after x initiated treatments was 
calculated as follows (Kalbfleisch and Prentice, 1980): [1 -  11(1 -  
number of pregnant women in treatment /^number of women at risk 
in treatment ^)]X100%. In this formula, II indicates the product of 
the terms specified within the parentheses for each of the a: treatments.
Results
The numbers of women who achieved pregnancy per IVF 
treatment and who stopped after each treatment without 
becoming pregnant are shown in Table I. Note that the 
number of women who stopped treatment after a specific IVF 
cycle was the highest for the calculation of ongoing pregnancy, 
then for clinical pregnancy, and the lowest for the positive 
pregnancy test result. This was because all women who stopped 
treatment before achieving an ongoing pregnancy were also 
included in the numbers of those not achieving a positive 
pregnancy test result or a clinical pregnancy. The reverse 
situation did not apply. After the first IVF treatment, 42 women 
were advised to stop further treatment because of a medical 
indication; the corresponding figures were 58, 39 and 15 after 
the second, third and fourth treatments respectively.
The results of the calculations of the cumulative rates for a 
positive pregnancy test result, clinical pregnancy and ongoing 
pregnancy based on each of the three assumptions are shown 
in Figure 1A-C and Table I. As expected, the cumulative 
pregnancy rates were the lowest with assumption I, highest 
with assumption II and intermediate with assumption III 
(Table I). The cumulative pregnancy rates after five successive 
IVF treatments ranged from 37 to 51% for a positive pregnancy 
test result, from 33 to 55% for a clinical pregnancy and from 
30 to 56% for an ongoing pregnancy. The cumulative pregnancy 
rates calculated by taking into account the reason for early 
cessation were 41% for a positive pregnancy test result, 38% 
for a clinical pregnancy and 34% for an ongoing pregnancy.
Discussion
In most of the studies that present cumulative pregnancy rates, 
the implicit assumption is that the women who stop IVF 
treatment before the occurrence of pregnancy have the same 
probability of becoming pregnant as those who continue. The 
consequence is an overestimation of the cumulative pregnancy 
rates, especially at higher IVF treatment numbers where many 
women stop further treatment. More realistic cumu­
lative pregnancy rates can be estimated by incorporating the 
reason for the early cessation of the IVF treatment in the 
assumption. Cumulative pregnancy rates based on the third 
assumption, which takes into account a medical indication for 
the cessation of IVF treatment, will be the most reliable. 
However, as the probability of pregnancy in those with a 
medical indication for stopping treatment is assumed to be 
zero, it is reasonable to expect the cumulative pregnancy rate 
to be slightly underestimated. In particular, at higher treatment 
numbers this assumption will result in a slight underestimation, 
as women who received a medical indication for stopping 
further treatment only after the third or fourth cycle had 
reasonable results in at least one treatment cycle.
The deviations in the cumulative pregnancy rates found 
when using the different assumptions are highly dependent on 
the number of women who discontinued treatment before the 
occurrence of pregnancy. The overestimation of the real 
cumulative pregnancy rate by a life-table analysis (which uses 
the assumption that those who stop treatment have the same 
probability of becoming pregnant as those who continue) will
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be particularly large in clinics with a high percentage of 
patients for whom the IVF procedure is mainly performed 
for diagnostic purposes before a final decision is made to 
continue IVF treatment, e.g. in cases of severe male infertility, 
unexplained infertility problems or a high level of follicle 
stimulating hormone in young women. In those cases, the 
method for the calculation of the cumulative pregnancy rate 
by taking into account whether or not one stopped treatment 
because of a medical indication (assumption III) is highly 
recommended.
In a recent study, Alsalili e ta l  (1995) calculated cumulative 
pregnancy rates by using a life-table analysis. They discussed 
the importance of the underlying assumption that the prob­
ability of pregnancy is the same for those who continue and 
those who discontinue treatment. They state that: ‘The two 
factors, prognostic information...’ (which is used to decide 
whether or not to continue treatment) and successive cycle 
reduction in fertility, work in opposite directions on the 
assumption that pregnancy rates are constant for treated and 
non-treated individuals. Acknowledging its limitations, life- 
table analysis remains the conventional method for assessing 
IVF success and comparing results from different IVF centres/ 
Their argument for the two factors working in opposite 
directions is, however, incorrect. This can be explained by 
considering that those who stop treatment because of poor 
prior results (i.e. prognostic information) would have had a 
lower probability of pregnancy than those women who con- 
tinued treatment, even if it is assumed that those who continued 
treatment would have a lower chance of pregnancy than in 
their previous cycle (i.e. successive cycle reduction). It seems 
that the authors confused the assumption made in life-table 
analysis: the probability of pregnancy for those who continue 
and those who discontinue treatment is not assumed to be the 
same at every cycle but in fact it applies to a specific cycle. 
Thus, the overestimation when using life-table analysis 
remains.
One result that might seem strange is that the estimated
cumulative pregnancy rate after five treatments was higher
for ongoing pregnancy than for clinical pregnancy and lowest
for a positive pregnancy test result when using assumption II
(i.e. women who stopped treatment had the same probability
of pregnancy as those who continued), as shown in Table I.
However, this can be explained by looking at the denominator,
i.e. the number of women at risk. All women who had not yet
achieved a pregnancy but had stopped treatment are excluded
from , the denominator. As for the calculation of cumulative
rates per type of pregnancy, women should only be included
if they did not achieve that particular kind of pregnancy; notice
that the numbers of women included at the fifth cycle are not
the same for the three definitions of pregnancy. From Table I
t
it can be inferred that only 11 women received a fifth IVF 
treatment because they had not achieved an ongoing pregnancy 
in the previous four cycles. Only six of them had not achieved 
a clinical pregnancy and four did not even have a positive 
pregnancy test result. As three and two of the women who 
were excluded from the calculation of the cumulative rate for 
a positive pregnancy test and a clinical pregnancy after the 
fifth cycle, respectively, achieved ongoing pregnancy during
the fifth cycle, the cumulative pregnancy rate after the fifth 
cycle was higher for an ongoing pregnancy than for a clinical 
pregnancy or a positive pregnancy test result.
Comparison of the cumulative pregnancy rates between 
clinics and between types of assisted reproductive techniques 
can be very misleading. Reasons for this are not only the use 
of different definitions of pregnancy and the kind of assumption 
used to calculate the cumulative pregnancy rates, but also 
differences in the characteristics of the populations (e,g. age, 
type of infertility, reproductive history), the characteristics 
of treatments (e.g. type of ovulation stimulation protocol, 
experience of the IVF clinic) and the number of and reason 
for couples discontinuing treatment before the occurrence 
of pregnancy. Caution is thus required when calculating, 
interpreting and comparing cumulative pregnancy rates. The 
figures presented here are only valid for the IVF clinic in 
Nijmegen, The Netherlands, between 1988 and 1993.
Multivariable prognostic models are necessary to take into 
account the influence of patient and treatment characteristics. 
In these models, the reason for cessation, i.e. a medical 
indication or another reason, should also be considered when 
calculating the cumulative pregnancy rate for specific patients. 
Only in that case can the cumulative pregnancy rate give 
reliable information for the candidate IVF patients.
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